PATENT CLAIM ANALYSIS

Application Number: 16007095
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "489000"]

Abstract:
Disclosed herein are compositions and methods for treating lung disorders including lung tumors by pulmonary administration of compositions comprising taxane particles such as docetaxel or paclitaxel particles.

Claim (Index 5):
The method of  claim 1 , wherein the taxane particles have a specific surface area (SSA) of at least 10 m 2 /g, or at least 12 m 2 /g, 14 m 2 /g, 16 m 2 /g, 18 m 2 /g, 20 m 2 /g, 25 m 2 /g, 30 m 2 /g, 32 m 2 /g, 34 m 2 /g, or 35 m 2 /g.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 94.0
- Lexical Diversity: 1.12
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15895197', '15174505', '13779625', '12436697', '15460552']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6988052772272842
- 35 USC 102 Novelty (BERT): 0.5236155375133017
- Combined Prediction Score: 0.681286303255886
- Mean Citation Score: 270.84776600000004
- Max Citation Score: 316.4046600000001
- Similarity Product: 210.21638365362887

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test